The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Rybrevant
Australian Public Assessment Report
Device/Product Name
Rybrevant
Active ingredients
Amivantamab
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04814-1-4
Submission Type
New biological entity
Decision
Approved for provisional registration